Stephanie Porter, PA
Physician Assistant · Norman, OKNPI 1366831455
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,477 of the $10,763 with a category attached, or 69.5%. 39 manufacturers reported payments, led by Tandem Diabetes Care, Inc. at 29.7% of the total. Among physician assistant clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 318 payments — averaging $33.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tandem Diabetes Care, Inc.$3K
- Novo Nordisk$1K
- Abbott$1K
- Lilly USA, LLC$822
- Sanofi-aventis U.S. LLC$471
- Corcept Therapeutics$464
- plus $4K from 33 others
What the payments were for
- Speaking & faculty fees$3,00028%
- Travel & lodging$2783%
- Food & beverage$7,47769%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tandem Diabetes Care, Inc. | 16 | $3,199 |
| Novo Nordisk | 48 | $1,078 |
| Abbott | 23 | $1,008 |
| Lilly USA, LLC | 38 | $822 |
| Sanofi-aventis U.S. LLC | 19 | $471 |
| Corcept Therapeutics | 19 | $464 |
| Dexcom, Inc. | 24 | $448 |
| AstraZeneca(2 entities) | 14 | $425 |
| Xeris Pharmaceuticals, Inc. | 16 | $309 |
| Insulet Corporation | 16 | $304 |
| Intuitive Surgical | 1 | $278 |
| Bayer | 10 | $251 |
| Medtronic | 5 | $208 |
| BETA Bionics, Inc. | 6 | $155 |
| AbbVie | 8 | $145 |
| Novartis | 2 | $124 |
| Cequr Corporation | 2 | $117 |
| Boehringer Ingelheim | 6 | $116 |
| Ascensia Diabetes Care US Inc. | 5 | $111 |
| Merck | 6 | $99 |
| Amgen | 5 | $75 |
| Sequel Med Tech, LLC | 3 | $71 |
| Chiesi USA, Inc. | 3 | $63 |
| IBSA Pharma Inc. | 3 | $53 |
| Lifescan, Inc. | 2 | $43 |
| Amryt Pharma Holdings Ltd | 2 | $42 |
| Antares Pharma, Inc. | 2 | $36 |
| Madrigal Pharmaceuticals | 1 | $32 |
| Currax Pharmaceuticals LLC | 2 | $26 |
| Neurocrine Biosciences, Inc. | 1 | $23 |
| Baxter Healthcare | 1 | $22 |
| Boston Scientific | 1 | $20 |
| Recordati_rare_diseases_inc. | 2 | $19 |
| Endo Pharmaceuticals Inc. | 1 | $19 |
| Echosens North America, Inc. | 1 | $19 |
| Hologic Sales And Service, LLC | 1 | $18 |
| Ascendis Pharma Endocrinology Inc | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Amneal Pharmaceuticals LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- t:slim X2 Insulin Pump with Control-IQ$3,000
- FreeStyle Libre$396
- Da Vinci Surgical System$278
- FARXIGA$237
- Ozempic$232
- FreeStyle Libre 2$156
- MINIMED 780G$124
- TZIELD$119
- FREESTYLE LIBRE 3$113
- LYUMJEV$111
- Korlym$102
- LEQVIO$102
How this compares
$10,763 in reported general payments places this provider in the 95th percentile of 1,491 physician assistant providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 226 | $409,182 |
| OzempicSemaglutide | 156 | $307,440 |
| Tresiba Flextouch U-200Insulin Degludec | 83 | $133,432 |
| JardianceEmpagliflozin | 94 | $121,051 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 56 | $116,125 |
| FarxigaDapagliflozin Propanediol | 55 | $69,913 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 28 | $61,254 |
| TrulicityDulaglutide | 42 | $60,719 |
| FiaspInsulin Aspart (Niacinamide) | 42 | $58,057 |
| LyumjevInsulin Lispro-Aabc | 32 | $46,446 |
| Xultophy 100-3.6Insulin Degludec/Liraglutide | 23 | $39,090 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 39 | $34,452 |
| Lyumjev Kwikpen U-100Insulin Lispro-Aabc | 44 | $31,018 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 30 | $29,041 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 13 | $26,903 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Lyumjev, Humalog | $822 | $521,269314 claims |
| Novo NordiskOzempic, Fiasp, Xultophy 100-3.6, Novolog | $1,078 | $408,172233 claims |
| Boehringer IngelheimJardiance | $116 | $121,05194 claims |
| AstraZenecaFarxiga | $425 | $69,91355 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $471 | $26,90313 claims |
| MerckJanuvia | $99 | $12,98516 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $15 | $31053 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,491 physician assistant providers in Oklahoma.
Other physician assistant in Norman
- Eric CampbellEdmond$246K
- Jennifer SmithOklahoma City$134K
- Christy NiehuesMustang$28K
- Matthew PattonTulsa$24K
- Sarah HawkOklahoma City$23K
- Gavin ChristieEdmond$19K
- Michelle GreenTulsa$18K
- Muge ParkTulsa$17K
- Rose RamirezTulsa$15K
- Melissa RohrerTulsa$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.